BioResearch
Gene Therapy Enhances Survival of Cancer-Killing Dendritic Cells
Researchers working with a mouse cancer model have found that insertion of the gene for a modified form of the enzyme Akt1 greatly increased the efficacy of experimental anti-cancer vaccines by extending the lives of the animals' immune system dendritic cells. More...20 Dec 2006
In Other News
Research and Discovery Alliance for Pharmacology
Stratagene Acquires Rights to Predictive Genes for Bladder Cancer
Mathematical Model Predicts Aggressiveness of Tumors
Designer Compound May Provide Customized Cancer Therapy
Deadly Disorder Linked to Cholesterol Accumulation in Brain
Growing European Market for Gene Expression
Hybrid Toxin Stops Bone Cancer by Targeting VEGF Receptors
Drug Combination Overwhelms Leukemia Cells
Activated Wnt Signaling Triggers Limb Regeneration
Attractin Mediates Invasiveness of Certain Brain Tumors
Gene Therapy Prevents Seizures in Rat Model of Epilepsy
Conjugation to a Dendrimer Reduces Anti-Cancer Drug Toxicity
Mouse Study Links Diabetes to Depressed ACE2 Activity
Intravenous Gene Therapy Protects Tissue During Whole-Body Radiation
Stem Cell Transplants Pose Long-Term Cancer Risk
Neuroglobin Defends the Brain From Shock and Stroke
Vaccine Shows Potential Against Early-Stage Breast Cancer
X-rays Show How Nanoscale Structure of Bones Resist Strain
Vaccine Triggers Immune System to Destroy Cancer Cells
Glutamate Inhibitors Protect Against Nerve Damage in Huntington's
Dual Gene Activation Characterizes Breast Tumors
Antigen Cocktail Protects Mice from Staph Infection
Sea Bacteria May Offer New Way to Make Cancer Drugs
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.







 Analyzer.jpg)